This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andl, T. Articles by Bosch, F. X. Search for Related Content PubMed PubMed Citation Articles by Andl, T. Articles by Bosch, F. X.

Etiological Involvement of Oncogenic Human Papillomavirus in Tonsillar Squamous Cell Carcinomas Lacking Retinoblastoma Cell Cycle Control¹

Molekularbiologisches Labor, Hals-Nasen-Ohren-Klinik [T. A., A. P., R. E., W. K., M. H., A. D., H. W., F. X. B.], Institut für Medizinische Biometrie [C. C.], Universität Heidelberg, Angewandte Tumor Virologie, Deutsches Krebsforschungszentrum [T. K., T. N.], 69120 Heidelberg, Germany

Two hundred eight primary squamous cell carcinomas of the head and neck have been analyzed with respect to the presence of the retinoblastoma tumor suppressor protein, pRb. Of these, 23 tumors (11%) that preferentially localized to the tonsils revealed complete absence or dramatic reduction in the amount of pRb. Other cell cycle components, cyclin D1 and p16^INK4A, which are intimately related to pRb through an autoregulatory loop, were also dramatically decreased or overexpressed, respectively, in these pRb-defective tumors. On the other hand, the majority of the pRb-defective tumors contained the wild-type p53 gene. No evidence was found for genetic defects at the Rb locus in these tumors. Very significantly, in 11 of 12 pRb-defective tonsillar tumors, but in none of 9 pRb-positive tonsillar tumors (P < 10^-7), DNA of oncogenic human papillomavirus types was identified, providing a strong indication for a human papillomavirus-associated etiology of these tumors and suggesting the functional inactivation of the pRb protein by the viral E7 gene product. In comparison to all head and neck squamous cell carcinomas studied, the pRb-defective tonsillar tumors were in general more poorly differentiated (P = 0.0059), and they were all metastatic at the time of resection. Of particular clinical interest, despite these adverse histopathological factors, the clinical outcome for these patients was relatively favorable, strongly implying that the pRb-defective tumors responded uniformly well toward postoperative radiation therapy.

¹ The work was supported by grants from the Verein zur Förderung der Krebsforschung in Deutschland e.V. and the Tumorzentrum Heidelberg/Mannheim.

² To whom requests for reprints should be addressed, at Molekularbiologisches Labor, Universitaet-HNO-Klinik, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. Phone: 06221/566751; Fax: 06221/564604; E-mail: Franz_Bosch@krzmail.krz.uniheidelberg.de.

Received 9/ 3/97. Accepted 11/19/97.

This article has been cited by other articles:

				N. Choong and E. Vokes Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer CA Cancer J Clin, January 1, 2008; 58(1): 32 - 53. [Abstract] [Full Text] [PDF]

				D M Muirhead, H T Hoffman, and R A Robinson Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma J. Clin. Pathol., July 1, 2006; 59(7): 711 - 715. [Abstract] [Full Text] [PDF]

				C. Fakhry and M. L. Gillison Clinical Implications of Human Papillomavirus in Head and Neck Cancers J. Clin. Oncol., June 10, 2006; 24(17): 2606 - 2611. [Abstract] [Full Text] [PDF]

				P. M. Weinberger, Z. Yu, B. G. Haffty, D. Kowalski, M. Harigopal, J. Brandsma, C. Sasaki, J. Joe, R. L. Camp, D. L. Rimm, et al. Molecular Classification Identifies a Subset of Human Papillomavirus-Associated Oropharyngeal Cancers With Favorable Prognosis J. Clin. Oncol., February 10, 2006; 24(5): 736 - 747. [Abstract] [Full Text] [PDF]

				Z. Yu, P. M. Weinberger, B. G. Haffty, C. Sasaki, C. Zerillo, J. Joe, D. Kowalski, J. Dziura, R. L. Camp, D. L. Rimm, et al. Cyclin D1 Is a Valuable Prognostic Marker in Oropharyngeal Squamous Cell Carcinoma Clin. Cancer Res., February 1, 2005; 11(3): 1160 - 1166. [Abstract] [Full Text] [PDF]

				B. J. M. Braakhuis, P. J. F. Snijders, W.-J. H. Keune, C. J. L. M. Meijer, H. J. Ruijter-Schippers, C. R. Leemans, and R. H. Brakenhoff Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus J Natl Cancer Inst, July 7, 2004; 96(13): 998 - 1006. [Abstract] [Full Text] [PDF]

				S Syrjanen HPV infections and tonsillar carcinoma J. Clin. Pathol., May 1, 2004; 57(5): 449 - 455. [Abstract] [Full Text] [PDF]

				S. Begum, M. L. Gillison, M. A. Ansari-Lari, K. Shah, and W. H. Westra Detection of Human Papillomavirus in Cervical Lymph Nodes: A Highly Effective Strategy for Localizing Site of Tumor Origin Clin. Cancer Res., December 15, 2003; 9(17): 6469 - 6475. [Abstract] [Full Text] [PDF]

				W. Li, C. H. Thompson, D. Xin, Y. E. Cossart, C. J. O'Brien, E. B. McNeil, K. Gao, R. A. Scolyer, and B. R. Rose Absence of Human Papillomavirus in Tonsillar Squamous Cell Carcinomas from Chinese Patients Am. J. Pathol., December 1, 2003; 163(6): 2185 - 2189. [Abstract] [Full Text]

				K. R. Dahlstrom, K. Adler-Storthz, C. J. Etzel, Z. Liu, L. Dillon, A. K. El-Naggar, M. R. Spitz, J. T. Schiller, Q. Wei, and E. M. Sturgis Human Papillomavirus Type 16 Infection and Squamous Cell Carcinoma of the Head and Neck in Never-Smokers: A Matched Pair Analysis Clin. Cancer Res., July 1, 2003; 9(7): 2620 - 2626. [Abstract] [Full Text] [PDF]

				E. Ringstrom, E. Peters, M. Hasegawa, M. Posner, M. Liu, and K. T. Kelsey Human Papillomavirus Type 16 and Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., October 1, 2002; 8(10): 3187 - 3192. [Abstract] [Full Text] [PDF]

				R. P. Takes, R. J. Baatenburg de Jong, M. J. R. C. Alles, C. A. Meeuwis, H. A. M. Marres, P. P. M. Knegt, G. B. de la Riviere, P. C. M. de Wilde, W. J. Mooi, J. Hermans, et al. Markers for Nodal Metastasis in Head and Neck Squamous Cell Cancer Arch Otolaryngol Head Neck Surg, May 1, 2002; 128(5): 512 - 518. [Abstract] [Full Text] [PDF]

				J. Mork, A. K. Lie, E. Glattre, S. Clark, G. Hallmans, E. Jellum, P. Koskela, B. Moller, E. Pukkala, J. T. Schiller, et al. Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck N. Engl. J. Med., April 12, 2001; 344(15): 1125 - 1131. [Abstract] [Full Text] [PDF]

				M. Orjuela, V. P. Castaneda, C. Ridaura, E. Lecona, C. Leal, D. H. Abramson, I. Orlow, W. Gerald, and C. Cordon-Cardo Presence of Human Papilloma Virus in Tumor Tissue from Children with Retinoblastoma: An Alternative Mechanism for Tumor Development Clin. Cancer Res., October 1, 2000; 6(10): 4010 - 4016. [Abstract] [Full Text]

				M. L. Gillison, W. M. Koch, R. B. Capone, M. Spafford, W. H. Westra, L. Wu, M. L. Zahurak, R. W. Daniel, M. Viglione, D. E. Symer, et al. Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers J Natl Cancer Inst, May 3, 2000; 92(9): 709 - 720. [Abstract] [Full Text] [PDF]

				E. R. Sauter, M. Herlyn, S.-C. Liu, S. Litwin, and J. A. Ridge Prolonged Response to Antisense Cyclin D1 in a Human Squamous Cancer Xenograft Model Clin. Cancer Res., February 1, 2000; 6(2): 654 - 660. [Abstract] [Full Text]

				E. R. Sauter, M. Nesbit, S. Litwin, A. J. P. Klein-Szanto, S. Cheffetz, and M. Herlyn Antisense Cyclin D1 Induces Apoptosis and Tumor Shrinkage in Human Squamous Carcinomas Cancer Res., October 1, 1999; 59(19): 4876 - 4881. [Abstract] [Full Text] [PDF]

				T. Sano, T. Oyama, K. Kashiwabara, T. Fukuda, and T. Nakajima Expression Status of p16 Protein Is Associated with Human Papillomavirus Oncogenic Potential in Cervical and Genital Lesions Am. J. Pathol., December 1, 1998; 153(6): 1741 - 1748. [Abstract] [Full Text] [PDF]